Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2026-02-26 @ 4:30 PM
Study NCT ID:
NCT02955251
Status:
COMPLETED
Last Update Posted:
2020-07-20
First Post:
2016-11-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of ABBV-428, an Immunotherapy, in Subjects With Advanced Solid Tumors
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-11-18
Start Date Type:
ACTUAL
Primary Completion Date:
2019-10-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-10-29
Completion Date Type:
ACTUAL
First Submit Date:
2016-11-02
First Submit QC Date:
None
Study First Post Date:
2016-11-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-17
Last Update Post Date:
2020-07-20
Last Update Post Date Type:
ACTUAL